Scientists at Nestlé are working on a new formula for slow-release coffee, something that could conceivably spread the effects of caffeine out over a longer period of time.
The Coca-Cola Company says it wants to set the record straight on its role in funding scientific research, after coming under fire for funding a program which says there is ‘no compelling evidence’ that sugary drinks and diets are responsible for obesity.
Quaker's involvement in oat research does not need to be compromised by its interest in the sector and should be supported given the lack of funding from elsewhere, says an analyst.
The Institute of Food Technologists (IFT) has launched a global Certified Food Scientist (CFS) program to recognize applied scientific knowledge and skills in the food industry.
Researchers at the University of Georgia are exploring whether rosemary or black pepper could tackle mental fatigue as part of a series of studies financed by the McCormick Science Institute.
DSM has joined the Leadership Council of the New York Academy of Sciences’ Global Nutrition Science Research Initiative as the company continues to tackle the problem of hidden hunger.
Planning to attend the IFT Annual Meeting and Food Expo 2010 in Chicago? Meet the dedicated editorial team behind FoodNavigator-USA.com and NutraIngredients-USA.com.
The FDA needs to improve its oversight of GRAS (generally recognized as safe) food ingredients, claims a new report from the Government Accountability Office (GAO).
Cranberry giants Ocean Spray have appointed Dr Christina Khoo to the position of manager of research sciences, emphasizing the company’s continued drive of science.
The US Food and Drug Administration estimates that it will receive only one nutrient content claim notification and two health claim notifications per year, according to a notice to be published in the Federal Register.
Nutrition studies of beverages funded solely by industry are four
to eight times more likely to report favourable conclusions for the
sponsors than studies with no industry funding, say researchers
from the US.
One cannot envy the chief executive faced with a scientific study
that casts doubt over the efficacy or safety of his core product.
But avoiding a sales slump, media vilification and even charges of
fraud means squaring up to such...
